Course: Prevalence of and Short-term Changes in Conjunctival Manifestations Among Patients With SARS-CoV-2 Infection
CME Credits: 1.00
Released: 2022-04-19
Studies suggest that SARS-CoV-2 can infect the conjunctival mucosa.- Signs of ocular involvement have been reported in 11% to 32% of SARS-CoV-2 cases, with a rate of conjunctival swab (CS) positivity from 0% to 57%. Previous studies lacked a predetermined sample size, relied on questionnaires and/or interviews, or analyzed nonhospitalized and hospitalized patients receiving anti-inflammatory agents. In this study, we assessed the prevalence of SARS-CoV-2–related conjunctival manifestations and CS positivity on hospital admission (T1) and 3 days thereafter (T2) for a predetermined sample of patients not receiving anti-inflammatory treatment.
Educational Objective
To identify the key insights or developments described in this article
View Full Course